These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18430749)

  • 1. Enhancement of ventricular gap-junction coupling by rotigaptide.
    Lin X; Zemlin C; Hennan JK; Petersen JS; Veenstra RD
    Cardiovasc Res; 2008 Aug; 79(3):416-26. PubMed ID: 18430749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gap junction modifier rotigaptide decreases the susceptibility to ventricular arrhythmia by enhancing conduction velocity and suppressing discordant alternans during therapeutic hypothermia in isolated rabbit hearts.
    Hsieh YC; Lin JC; Hung CY; Li CH; Lin SF; Yeh HI; Huang JL; Lo CP; Haugan K; Larsen BD; Wu TJ
    Heart Rhythm; 2016 Jan; 13(1):251-61. PubMed ID: 26188250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiarrhythmic peptide rotigaptide (ZP123) increases gap junction intercellular communication in cardiac myocytes and HeLa cells expressing connexin 43.
    Clarke TC; Thomas D; Petersen JS; Evans WH; Martin PE
    Br J Pharmacol; 2006 Mar; 147(5):486-95. PubMed ID: 16415913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological modulation of gap junction function with the novel compound rotigaptide: a promising new principle for prevention of arrhythmias.
    Kjølbye AL; Haugan K; Hennan JK; Petersen JS
    Basic Clin Pharmacol Toxicol; 2007 Oct; 101(4):215-30. PubMed ID: 17845503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of enhanced gap junctional conductance on ventricular conduction in explanted hearts from patients with heart failure.
    Wiegerinck RF; de Bakker JM; Opthof T; de Jonge N; Kirkels H; Wilms-Schopman FJ; Coronel R
    Basic Res Cardiol; 2009 May; 104(3):321-32. PubMed ID: 19139945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance of intercellular coupling by the antiarrhythmic peptide rotigaptide suppresses arrhythmogenic discordant alternans.
    Kjølbye AL; Dikshteyn M; Eloff BC; Deschênes I; Rosenbaum DS
    Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H41-9. PubMed ID: 17982010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving cardiac gap junction communication as a new antiarrhythmic mechanism: the action of antiarrhythmic peptides.
    Dhein S; Hagen A; Jozwiak J; Dietze A; Garbade J; Barten M; Kostelka M; Mohr FW
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Mar; 381(3):221-34. PubMed ID: 19943035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs.
    Shiroshita-Takeshita A; Sakabe M; Haugan K; Hennan JK; Nattel S
    Circulation; 2007 Jan; 115(3):310-8. PubMed ID: 17224477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiarrhythmic peptide analog rotigaptide (ZP123) stimulates gap junction intercellular communication in human osteoblasts and prevents decrease in femoral trabecular bone strength in ovariectomized rats.
    Jørgensen NR; Teilmann SC; Henriksen Z; Meier E; Hansen SS; Jensen JE; Sørensen OH; Petersen JS
    Endocrinology; 2005 Nov; 146(11):4745-54. PubMed ID: 16109789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cardiac gap-junction coupling: effects of antiarrhythmic peptide AAP10.
    Hagen A; Dietze A; Dhein S
    Cardiovasc Res; 2009 Jul; 83(2):405-15. PubMed ID: 19176598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic model for ventricular junctional conductance during the cardiac action potential.
    Lin X; Gemel J; Beyer EC; Veenstra RD
    Am J Physiol Heart Circ Physiol; 2005 Mar; 288(3):H1113-23. PubMed ID: 15513960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiarrhythmic peptide rotigaptide (ZP123) increases connexin 43 protein expression in neonatal rat ventricular cardiomyocytes.
    Stahlhut M; Petersen JS; Hennan JK; Ramirez MT
    Cell Commun Adhes; 2006; 13(1-2):21-7. PubMed ID: 16613777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with the gap junction modifier rotigaptide (ZP123) reduces infarct size in rats with chronic myocardial infarction.
    Haugan K; Marcussen N; Kjølbye AL; Nielsen MS; Hennan JK; Petersen JS
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):236-42. PubMed ID: 16495761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connexin40 and connexin43 determine gating properties of atrial gap junction channels.
    Lin X; Gemel J; Glass A; Zemlin CW; Beyer EC; Veenstra RD
    J Mol Cell Cardiol; 2010 Jan; 48(1):238-45. PubMed ID: 19486903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar arrhythmicity in hypertrophic and fibrotic cardiac cultures caused by distinct substrate-specific mechanisms.
    Askar SF; Bingen BO; Schalij MJ; Swildens J; Atsma DE; Schutte CI; de Vries AA; Zeppenfeld K; Ypey DL; Pijnappels DA
    Cardiovasc Res; 2013 Jan; 97(1):171-81. PubMed ID: 22977008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of intercellular coupling stabilizes spiral-wave reentry, whereas enhancement of the coupling destabilizes the reentry in favor of early termination.
    Takemoto Y; Takanari H; Honjo H; Ueda N; Harada M; Kato S; Yamazaki M; Sakuma I; Opthof T; Kodama I; Kamiya K
    Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H578-86. PubMed ID: 22707561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological modulation of cardiac gap junctions to enhance cardiac conduction: evidence supporting a novel target for antiarrhythmic therapy.
    Eloff BC; Gilat E; Wan X; Rosenbaum DS
    Circulation; 2003 Dec; 108(25):3157-63. PubMed ID: 14656916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of gap junctions in stretch-induced atrial fibrillation.
    Ueda N; Yamamoto M; Honjo H; Kodama I; Kamiya K
    Cardiovasc Res; 2014 Nov; 104(2):364-70. PubMed ID: 25183791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of rotigaptide, a gap junction modifier, on defibrillation energy and resuscitation from cardiac arrest in rabbits.
    Zhong JQ; Laurent G; So PP; Hu X; Hennan JK; Dorian P
    J Cardiovasc Pharmacol Ther; 2007 Mar; 12(1):69-77. PubMed ID: 17495260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotigaptide (ZP123) reverts established atrial conduction velocity slowing.
    Haugan K; Kjølbye AL; Hennan JK; Petersen JS
    Cell Commun Adhes; 2005; 12(5-6):271-8. PubMed ID: 16531322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.